webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Aminooxy-PEG2-BCN

  CAS No.: 2253965-14-7   Cat No.: BADC-01663 4.5  

Aminooxy-PEG2-BCN is a bioorthogonal ADC linker featuring aminooxy and bicyclononyne groups, facilitating rapid, copper-free click chemistry for site-specific antibody conjugation.

Aminooxy-PEG2-BCN

Structure of 2253965-14-7

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C19H31N3O6
Molecular Weight
397.47

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
5,8-Dioxa-2,11-diazatridecanoic acid, 13-(aminooxy)-12-oxo-, bicyclo[6.1.0]non-4-yn-9-ylmethyl ester
IUPAC Name
9-bicyclo[6.1.0]non-4-ynylmethyl N-[2-[2-[2-[(2-aminooxyacetyl)amino]ethoxy]ethoxy]ethyl]carbamate
Canonical SMILES
C1CC2C(C2COC(=O)NCCOCCOCCNC(=O)CON)CCC#C1
InChI
InChI=1S/C19H31N3O6/c20-28-14-18(23)21-7-9-25-11-12-26-10-8-22-19(24)27-13-17-15-5-3-1-2-4-6-16(15)17/h15-17H,3-14,20H2,(H,21,23)(H,22,24)
InChIKey
ZJQCJHPFLPLHDG-UHFFFAOYSA-N
Density
1.22±0.1 g/cm3
Boiling Point
645.5±55.0 °C at 760 mmHg

Aminooxy-PEG2-BCN is a bifunctional linker used in bioconjugation and chemical biology studies. Here are some key applications of Aminooxy-PEG2-BCN:

Site-Specific Protein Labeling: Aminooxy-PEG2-BCN is instrumental in site-specific labeling of proteins through oxime ligation. By targeting aldehyde or ketone functional groups on proteins, this linker facilitates the attachment of probes or therapeutic molecules. This enables highly specific molecular studies and targeted drug delivery.

Antibody-Drug Conjugates: This linker is employed in the development of antibody-drug conjugates (ADCs), which are targeted cancer therapies that combine an antibody specific to cancer cells with a cytotoxic drug. Aminooxy-PEG2-BCN allows the efficient and stable conjugation of the drug to the antibody. This results in targeted delivery of the drug to cancer cells while minimizing off-target effects.

Biomaterial Functionalization: Aminooxy-PEG2-BCN is used to functionalize surfaces of biomaterials for various biomedical applications. By attaching specific biomolecules to the surface of implants or tissue engineering scaffolds, it enhances biocompatibility and interacts with biological tissues. This promotes improved integration and functionality in medical devices.

Chemical Biology Probes: Researchers use Aminooxy-PEG2-BCN to develop chemical biology probes for studying cellular processes and molecular interactions. Its ability to form stable conjugates with various biomolecules allows for the design of specialized probes. This facilitates the exploration of complex biological pathways and aids in drug discovery research.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Bocaminooxyacetamide-PEG2-Azido | Mal(Br2)-Aca | Amino-PEG6-propionic acid | Methyltetrazine-amido-N-bis(PEG4-acid) | Boc-aminooxy-ethyl-SS-propanol | SC209 intermediate-1 | Bocaminooxyacetamide-PEG3-alkyne | Boc-Aminooxy-PEG2-bromide | Macropa-NCS | Indole-C2-amide-C2-NH2 | Aminooxy-PEG2-BCN
Send Inquiry
Verification code
Inquiry Basket